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ARF1 is directly involved in dynamin-independent 
endocytosis
Sudha Kumari1 and Satyajit Mayor1,2
Endocytosis of glycosylphosphatidyl inositol (GPI)-anchored proteins (GPI-APs) and the fluid phase takes place primarily through 
a dynamin- and clathrin-independent, Cdc42-regulated pinocytic mechanism. This mechanism is mediated by primary carriers 
called clathrin-independent carriers (CLICs), which fuse to form tubular early endocytic compartments called GPI-AP enriched 
endosomal compartments (GEECs). Here, we show that reduction in activity or levels of ARF1 specifically inhibits GPI-AP and 
fluid-phase endocytosis without affecting other clathrin-dependent or independent endocytic pathways. ARF1 is activated at 
distinct sites on the plasma membrane, and by the recruitment of RhoGAP domain-containing protein, ARHGAP10, to the 
plasma membrane, modulates cell-surface Cdc42 dynamics. This results in the coupling of ARF1 and Cdc42 activity to regulate 
endocytosis at the plasma membrane. These findings provide a molecular basis for a crosstalk of endocytosis with secretion by 
the sharing of a key regulator of secretory traffic, ARF1.
Internalization of cargo at the cell surface takes place via multiple clath-
rin-dependent and independent pathways1–3. Many of these mechanisms 
use the large GTPase dynamin to facilitate vesicle fission at the plasma 
membrane, although other pathways function in its absence. A dynamin-
independent, Cdc42-regulated pinocytic pathway is one such example4; 
it does not use the coat-proteins, caveolin or clathrin, nor the scission 
effector, dynamin. Nascent endocytic vesicles (CLICs) in this pathway 
have been recently identified5, and they fuse to form early endosomal 
intermediates, GEECs4. This is distinct from the early sorting endosomal 
compartment which also contains clathrin-dependent endocytic cargo6. 
Although the GEEC pathway is responsible for endocytosis of specific 
components of the membrane such as GPI-APs and cholera toxin (CTx) 
bound to its ganglioside receptor (GM1), it also facilitates pinocytosis 
in a variety of cell lines4–8.
Recently, we have shown that cholesterol-sensitive Cdc42 activa-
tion results in recruitment of actin-polymerization machinery to spe-
cific foci at the plasma membrane, promoting endocytosis via CLICs 
into GEECs9. This results in an endocytic pathway that is sensitive 
to perturbations of cholesterol levels and actin polymerization. To 
date, very few other components of this pathway have been identi-
fied. Flotillin1 has been reported to be required for internalization 
via a clathrin and dynamin independent pathway10, and CtBP1–BARS 
protein has been implicated in a dynamin-independent pinocytic 
mechanism11. Further downstream, Rab5 and PI(3)K are recruited 
to early endocytic intermediates of the GEEC pathway, resulting in 
fusion with sorting endosomes6.
The functional significance of endocytosis via GEECs is expanding as 
we discover both specific cargo and molecular players that participate in 
this pathway; for example, folate uptake via GPI-anchored folate recep-
tors (FR-GPI), and the internalization of vacuolating toxins such as VacA 
and aerolysin, are mediated by this pathway3,12. Taking into account the 
diverse functions of GPI-AP cargo and the importance of fluid-phase 
endocytosis for a variety of cellular processes, it is imperative to under-
stand the molecular mechanism of the GEEC pathway.
Here, we have examined the role of the ADP-ribosylation factor (ARF) 
family of proteins that participate in multiple intracellular trafficking 
events13. Of the many family members13, ARF1 and ARF6 are the best 
characterized. ARF1 has a central role in vesicle formation during early 
and late secretory traffic14,15, whereas ARF6 is involved in regulating the 
actin cytoskeleton near the cell surface and has been implicated in mul-
tiple pathways of endocytosis16–8. We find that activated ARF1 is present 
at the plasma membrane and recruits ARHGAP10, a GAP for Cdc42, 
which, in turn, regulates endocytosis via the GEEC pathway.
REsuLTs
Modulation of ARF1 GTPase activity specifically affects 
endocytosis via the GEEC pathway
ARF1, a cytosolic GTPase with a relative molecular mass of 21,000 (Mr, 
21K), is recruited to Golgi membranes, where its location in the mem-
brane depends on GTP-binding19. The GDP-exchange deficient form of 
ARF1 (ARF1T31N) is primarily cytosolic, and behaves as dominant nega-
tive isoform of ARF1 activity when overexpressed20. To study the effect 
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of ARF1 on different pathways of endocytosis, uptake of endocytic cargo 
specific for each pathway in ARF1T31N-overexpressing CHO cells was 
quantitatively assessed (Fig. 1a). Endocytosis via the dynamin-dependent 
pathways, clathrin, caveolin or the RhoA-dependent processes were mon-
itored by measuring the extent of endocytosis of fluorescently-labelled 
transferrin (Tf) bound to the transferrin receptor (TfR), C6-Bodipy-lac-
tosylceramide (C6-LacCer) incorporated into the plasma membrane, or 
antibodies against the β-subunit of the interleukin 2 receptor (IL2R-β)21, 
respectively. Endocytosis via the GEEC pathway was assessed by moni-
toring uptake of surface-labelled folate receptor (FR–GPI) and TMR-
labelled Dextran (TMR–Dex), as probes for GPI-APs and the fluid-phase, 
respectively. Overexpression of ARF1T31N resulted in specific inhibition 
of FR–GPI and TMR–Dex uptake, whereas internalization of Tf (Fig. 1a) 
and C6-LacCer (see Supplementary information, Fig. S1a) were unaf-
fected. Although ARF1T31N caused a reduction in the surface levels of the 
IL2R-β, possibly due to its effect on IL2R-β exocytosis, endocytosis of 
IL2R-β was also unaffected (see Supplementary information, Fig. S1d).
The effect of ARF1T31N on the CLIC–GEEC pathway was not restricted 
to CHO cells. ARF1T31N expression inhibited FR–GPI and fluid-phase 
uptake in BHK cells (see Supplementary information, Fig. S2a), and 
the uptake of GEEC cargo, CTxB and fluid-phase in mouse embryonic 
fibroblasts (MEFs; Fig. 1b)5,6. In cells overexpressing ARF1T31N, steady-state 
levels of surface FR–GPI were increased (see Supplementary information, 
Fig. S2c), consistent with inhibition of GPI-AP endocytosis. ARF1 also 
plays a role in GPI-AP exocytosis, as surface delivery of GPI-APs (see 
Supplementary information, Fig. S2b) was also inhibited. In parallel, there 
was a reduction in surface levels of TfR (see Supplementary information, 
Fig. S2d), and together with alteration in morphology of TfR containing 
perinuclear-recycling compartment (Fig. 1a), these results suggest a role 
for ARF1 in the exocytosis of TfR and in TfR recycling22.
ARF1 depletion inhibits uptake via the GEEC pathway
ARF1T31N overexpression could inhibit endocytosis via GEECs by seques-
tering GDP exchange factors (GEFs) for other ARF family members, 
besides ARF1, as some GEFs have overlapping specificity for ARF1 and 
ARF6 (ref. 23). To discount this possibility, ARF1 protein was depleted 
using RNA interference (RNAi) methodology22. Approximately 60 h 
post-transfection with ARF1-specific short hairpin RNA (shRNA), cells 
appeared morphologically distinct (see Supplementary information, 
Fig. S2e) and ARF1 protein levels were reduced (Fig. 2b). The differences 
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Figure 1 GDP-exchange deficient ARF1 inhibits uptake of GPI-APs and 
the fluid-phase. (a) IA2.2 cells (CHO cells expressing FR-GPI (FR) and 
human TfR) were transiently transfected with ARF1T31N–GFP (outlined 
cells) for 18 h, and pulsed with Alexa568Mov19 Fabs and Alexa647 Tf 
(upper panels) or TMR–Dex (lower panels) for 10 min and processed 
for imaging. Images of internalized FR (red), TfR (green) and the 
fluid-phase (Fluid; red), are shown in grey-scale and colour merge. In 
transfected IA2.2 cells, the intracellular distribution of TfR containing 
perinuclear recycling compartment (REC) is altered, but Tf-uptake is 
unaffected. (b) MEFs transfected with ARF1T31N–GFP for 20 h, were 
pulsed with labelled probes for 5 min, fixed and imaged on a confocal 
microscope. Grey-scale and colour merge images of internalized Cy5–
CTxB (CTx; red) with TMR–Dex (lower panel; green) or Alexa568Tf (upper 
panel; green) from a single confocal section are shown (transfected 
cells are outlined). In transfected cells, uptake of CTxB is blocked and 
fluid uptake is significantly reduced while TfR-uptake is unaffected. 
(c) Histogram showing uptake of TfR, FR-GPI (normalized to surface 
receptor expression level) and fluid-phase in ARF1T31N transfected cells 
plotted as a ratio to corresponding uptake measured in control cells. 
The error bars represent the weighted mean of fluorescence intensities 
± s.e.m. (n = 61, 68, 100, 77, 63, 68; asterisks represent the cells 
transfected withARF1T31N). The scale bars in a and b represent 10 µm.
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in actin levels observed between control and shRNA-transfected cells 
may have resulted from the unequal number of cells loaded in different 
lysates. Although surface-receptor normalized Tf-uptake was unaffected, 
FR–GPI and the fluid-phase uptake were markedly reduced (Fig. 2a, c 
and d). Similar results were observed with another shRNA sequence 
against ARF1 (data not shown). A reduction in fluid-phase uptake by 
ARF1 shRNA-treated cells was also confirmed by a biochemical assay, 
using horseradish peroxidase (HRP) as a fluid-phase probe (Fig. 2e).
ARF1 depletion decreased both the number of fluid-containing endo-
somes and average endosomal intensities (see Supplementary informa-
tion, Fig. S3a, b and c). Furthermore, reduction in FR–GPI uptake after 
treatment with ARF1 shRNA was not due to decreased cell-surface levels, 
as FR-GPI endocytosis was reduced in ARF1 depleted cells at compara-
ble surface levels of FR–GPI (Fig. 2d). Similarly to results obtained with 
ARF1T31N expression, ARF1 depletion caused a reduction in cell-surface 
levels of TfR, consistent with previous studies on the role of ARF1 in mem-
brane recycling to the plasma membrane22,24. In ARF1-depleted cells, there 
was a detectable reduction in ARF3 levels (Fig. 2b). As the ARF1 target 
sequences do not share any significant sequence similarity with ARF3, 
this could be a result of coregulation of the protein products in CHO 
cells; however, further experiments are required to confirm this possibil-
ity. To directly test the involvement of ARF3, cells were transfected with 
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Figure 2 GEEC pathway is inhibited by depletion of ARF1 protein. (a, b) IA2.2 
cells cotransfected with pEGFP-N1 and the indicated shRNA or pSUPER 
vector (mock) were monitored for endocytosis as described in Fig. 1 (a) or 
harvested for western blotting (b). The histogram (b) shows the average (± s.
d.) of data from three experiments of normalized levels of ARF1 and ARF3 
in cells sorted for GFP fluorescence, where the amount of ARF protein as 
detected on western blots is normalized to the actin level per lane, and 
expressed as a ratio with respect to the value obtained in mock-transfected 
sample. (c) Histogram showing quantification of endocytosed probes in the 
cells expressing GFP, where each bar represents endocytosed fluorescence 
intensity (normalized surface receptor expression, TfR and FR) expressed 
relative to that measured in mock-transfected cells. Values plotted are 
weighted mean ± s.e.m. (n =  126, 116, 91, 95, 96, 103, 92, 90, 113, 100, 
110). (d) Scatter graph (and trend lines) showing variation of endocytosed 
PLR (FR–GPI) probe fluorescence intensities versus surface FR–GPI levels 
in individual cells transfected with indicated shRNA, from ≥80 cells per 
condition. FR–GPI uptake in cells was measured by monitoring endocytosed 
PLR as above, and surface levels of FR–GPI were quantified by measuring 
cell surface Cy5–Mov19 binding capacity. (e) Histogram showing the amount 
of endocytosed HRP in cells transfected with vector alone (control) or ARF1 
shRNA. Each bar represents the average of HRP activity normalized to the 
control, from two representative experiments ± s.d. Western blot shows the 
extent of reduction in ARF1 levels in cells taken for HRP uptake assays. The 
scale bar in a represents 20 µm.
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shRNA against ARF3 (Fig. 2a, c) and endocytosis was measured. In ARF3-
depleted cells, ARF3 levels were reduced without altering ARF1 levels 
(Fig. 2b); however, there was no reduction in fluid-phase, TfR or FR–GPI 
uptake (Fig. 2a, c). Similarly in cells depleted of ARF4 or ARF5, there was 
no detectable reduction in fluid uptake (see Supplementary information, 
Fig. S4). Moreover, expression of an RNAi-resistant form of ARF1 (Fig. 3a) 
that rescues the levels of ARF1 protein (Fig. 3c, d) restored fluid-phase 
uptake significantly (Fig. 3b). In cells transfected with ARF1 shRNA, Golgi 
morphology was altered to a more hazy appearance. Consistent with rescue 
of ARF1 function, the morphology of the Golgi was also restored in cells 
expressing the RNAi-resistant construct when cotransfected with shRNA 
against ARF1 (Fig. 3e). In contrast, depletion of ARF6 by shRNA did not 
affect endocytosis via the GEEC pathway (see Supplementary information, 
Fig. S3d). These results provide evidence that ARF1 is specifically required 
for endocytosis via the GEEC pathway.
Involvement of ARF1 in the GEEC pathway is distinct from its 
role in secretion
Recently, perturbation of Syntaxin6 function was shown to inhibit caveo-
lar uptake in human foreskin fibroblasts via inhibition of delivery of 
specific membrane components from the Golgi25. One explanation for 
the inhibition of endocytosis is an indirect effect by inhibition of mem-
brane traffic from the Golgi to the plasma membrane, as perturbation 
of ARF1 inhibits Golgi-to-cell surface delivery of GPI-APs and other 
cargo22,26,27 (see Supplementary information, Fig. S2b). Many secretory 
mutants in yeast are also known to have endocytic defects28. To test this 
hypothesis, cells were treated with Brefeldin A (BFA), a fungal metabolite 
that inhibits Golgi-to-cell surface traffic29 by blocking some ARF-GEFs 
and causing release of Golgi-localized ARF30,31. At concentrations of BFA 
where Golgi disassembly occurs, cell-surface delivery of newly synthe-
sized GPI-AP (CFP–GPI) was inhibited (Fig. 4a). However, endocyto-
sis of fluid phase and GPI-APs was measurably enhanced (Fig. 4b) via 
the GEEC pathway; endosomes formed during BFA-treatment contain 
endocytosed FITC–Dex and FR–GPI, but not Tf (see Supplementary 
information, Fig. S5a). A similar increase in uptake of a fluid-phase 
marker, HRP, on BFA treatment, has been reported in apical membrane 
of MDCK cells32. BFA treatment redistributed perinuclear-localized 
endocytosed Tf into extensive tubular compartments (data not shown) 
and reduced cell-surface levels of TfR, as previously reported33, but 
did not affect the internalization of Tf (Fig. 1a and see Supplementary 
information, Fig. S5c). Importantly, BFA-mediated increase in uptake 
via the GEEC pathway was reversed by ARF1T31N expression (Fig. 4c). 
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Figure 3 RNAi-resistant ARF1 reverts shRNA-mediated inhibition of the GEEC 
pathway. (a) Silent nucleotide substitutions in primers employed to create 
ARF1 RNAi-resistant (RR) form are highlighted in bold-type, with respect 
to positions in wild-type (WT) ARF1. (b) IA2.2 cells transfected with ARF1 
RR–GFP (control), ARF1 shRNA alone, or ARF1 shRNA and ARF1 WT–GFP 
(ARF1 shRNA/WT), or ARF1 shRNA and ARF1 RR–GFP (ARF1 shRNA/RR), 
were assessed for endocytosis of the fluid phase 60 h post-transfection. 
The histogram shows the quantification of fluid uptake in the indicated 
GFP-expressing cells. The error bars represent weighted mean, normalized 
to untransfected (control) cells, ± s.e.m.(n = 89, 81, 109, 84, 97). This 
experiment was repeated twice with similar results. (c) Cells transfected 
with indicated expression vectors for 60 h were fixed and processed for 
immunofluorescence microscopy to detect ARF1 levels. ARF1 RR–GFP 
overexpressing cells are marked with an asterisk. Note that coexpression 
of ARF1 RR–GFP with shRNA restores the ARF1-antibody staining levels 
comparable to unmarked cells in ARF1 RR panel. (d) Histogram representing 
the average GFP-fluorescence intensity in cells cotransfected with ARF1 
shRNA together with ARF1 WT–GFP or ARF1 RR–-GFP, normalized to GFP 
fluorescence levels in ARF1 RR–GFP transfected cells. The error bars represent 
weighted mean of GFP intensities detected in individual cells (arbitrary units, 
AU) ± s.e.m.(n = 120, 91). This experiment was repeated twice with similar 
results. (e) Overexpression of ARF1 RR–GFP in ARF1 shRNA transfected cells 
restores typical Golgi morphology as assessed by monitoring GM130 antibody 
staining pattern. Approximately 70% of cells transfected with ARF1 shRNA 
exhibited a disrupted Golgi pattern. Note GM130 staining in the shRNA-
expressing outlined cell versus surrounding untransfected cells. In contrast, 
only approximately 30% of cells exhibit this phenotype in cells cotransfected 
with ARF1 RR–GFP (n ≥80). The scale bars in b, c and e represent 10 µm.
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Thus, ARF1 is directly required for endocytosis via GEEC pathway, and 
not indirectly via modulation of exocytic delivery of specific membrane 
components. These results also demonstrate that ARF1 function in the 
GEEC pathway is BFA-insensitive, implicating a BFA-resistant GEF in 
ARF1 activation at the plasma membrane.
ARF1 modulates GEEC pathway via the adaptor ARHGAP10
ARF1 recruits ARHGAP10, a multi-domain protein (Mr, 200K) identified 
in yeast–two hybrid interaction screen of constitutively active ARF1 and 
ARF6 (refs 34, 35). ARHGAP10 has a distinct domain (ABD) neces-
sary for binding activated ARF1, and a GAP domain for RhoGTPases 
(R-G; Fig.5a). ABD encompasses a plekstrin homology (PH) domain, 
which does not bind to PtdIns, but is essential for ARF binding; the R-G 
domain possesses a relatively high GAP activity for Cdc42 compared 
with other Rho GTPases, and mutation of Arg 1183 to alanine in the R-G 
domain renders it incapable of GAP activity34. When overexpressed, these 
domains function as dominant-negative inhibitors for the generation of 
actin- patches on the Golgi34. To determine whether ARHGAP10 could 
couple the activation of ARF1 with a GAP activity for Cdc42, and in 
turn affect GPI-AP endocytosis, different domains of this protein were 
expressed (Fig. 5b). All the truncated domains, with the exception of 
the mutated RhoGAP domain, were capable of marginal but significant 
inhibition of endocytosis via GEECs (Fig. 5b), but not Tf uptake (see 
Supplementary Information, Fig. S5c).
Overexpression of ARF1Q71L, an isoform of ARF1 deficient in GTP 
hydrolysis, lead to increased FR–GPI internalization, as well as a more 
peripheral distribution of FR–GPI endosomes (Fig. 5b, c), suggest-
ing a role for ARF1 in post-endocytic trafficking. Persistent activa-
tion of ARF1 was also accompanied by a reduction in Tf uptake (see 
Supplementary information, Fig. S5c). This could arise due to seques-
tration of shared GTPase activating proteins (GAPs) for ARF1 and 
ARF6 that are reported to be involved in clathrin-mediated endocyto-
sis17. To determine whether ARHGAP10 exerts its effect downstream 
of activated ARF1, we examined whether coexpression of ARHGAP10 
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Figure 4 Brefeldin A inhibits surface delivery of GPI-APs, but enhances 
endocytosis via the GEEC pathway. (a) CHO cells transiently transfected 
with CFP–GPI were grown at 20 °C for 16 h and then shifted to 37 °C in 
presence (+BFA, 20 μg ml–1) or absence of Brefeldin A (–BFA) for 1 h. 
Surface levels of CFP–GPI, monitored by labelling cells with anti-CFP at 
4 °C, shows that BFA-treatment blocks exocytic delivery of CFP–GPI. The 
histogram shows anti-CFP antibody fluorescence at the surface of cells, 
normalized to total CFP–GPI expression per cell, and plotted as a ratio 
to the cell surface levels measured at 20 °C. The error bars represent 
weighted mean ± s.e.m. (n = 56, 40, 55). (b) IA2.2 cells, treated with 
BFA (20 μg ml–1 for 1 h at 37 °C) were assayed for FR–GPI and the fluid-
phase uptake as described in Fig. 1. In BFA-treated cells, fluid-phase 
and FR–GPI uptake is enhanced. (c) Histogram showing quantification of 
fluorescence of endocytosed probes (normalized to FR–GPI expression at 
the surface for FR-GPI uptake) in cells treated with BFA in the presence or 
absence of ARF1T31N transfection, represented as the ratio of uptake to that 
observed in untreated cells (control). The error bars represents weighted 
mean ± s.e.m. (n = 98, 139, 71 for fluid and 103, 112, 64 for FR).  The 
single and double asterisks represent P values (<0.002) from the indicated 
comparisons. The scale bars in a and b represent 10 µm.
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Figure 5 ARF1 functions via ARHGAP10. (a) Deletion constructs 
of ARHGAP10 with different domains. ARF binding domain, ABD; 
RhoGAP domain, R-G; ABD and R-G domain, ABD/R-G; R-G domain 
mutated for GAP activity, R-GR1183A. (b) IA2.2 cells transfected with 
either singly with GFP–ABD, HA–ARF1Q71L or with both constructs were 
assayed for endocytosis of FR–GPI. Expression of GFP–ABD reduces, 
whereas ARF1Q71L expression enhances FR–GPI uptake. Endocytosed 
FR–GPI is more peripherally distributed in ARF1Q71L-expressing cells. 
Coexpression of both proteins (outlined cells) shows that GFP–ABD 
expression antagonizes ARF1Q71L-mediated endocytic enhancement. 
(c) Histogram showing quantification of internalized FR–GPI in cells 
expressing the indicated combination of constructs, normalized to that 
measured in GFP-transfected cells. The error bars represent weighted 
mean ± s.e.m. (n = 66, 49, 54, 57, 50, 50, 44, 56, 49). The single 
asterisk and the double asterisk represent P values ≤0.01, and 0.2, 
respectively. (d) MEFs transfected with ARHGAP10 shRNA for 72 h 
were fixed and stained for actin organization and Golgi morphology 
(GM130). Note that in transfected cells, the actin distribution is altered 
and Golgi is dispersed. This F-actin reorganization is observed in 
approximately 30% of transfected cells and change in Golgi morphology 
is observed in approximately 60% cells. (e) Histogram showing levels of 
anti-V5 antibody staining in V5-tagged ARHGAP10 N-terminal domain 
coexpressed with eGFP-N1 (control) or ARHGAP10 shRNA in CHO cells. 
The error bars represent weighted mean of average of V5 intensities 
per cell ± s.e.m. (n = 97, 82). (f) MEFs expressing ARHGAP10 shRNA 
(outlined, green in merge) exhibit a reduction in fluid-phase uptake 
(outlined, right panel) compared with surrounding untransfected cells. 
Images are single confocal plane representing either transfection 
marker or internalized fluid. (g) Histogram showing the percentage 
of cells (MEFs) that exhibit a normal fluid-phase uptake in cells 
expressing GFP alone (control) or ARHGAP10 shRNA, when compared 
to untransfected cells. The error bars represent average of data from 
three independent experiments ± s.d. (n = 35, 56). The scale bars 
represent 20 µm.
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domains would inhibit enhanced FR–GPI internalization induced 
by ARF1Q71L (Fig. 5b, c). Different domains of ARHGAP10 reversed 
the ARF1Q71L-induced enhanced FR–GPI uptake to a similar extent 
(Fig. 5c). The extent of inhibition of uptake was comparable in R-G- 
and R-GR1183A-domain expressing cells, suggesting that the interaction 
between ARHGAP10 and Cdc42 was not dependent on the activity of 
the GAP domain. Taken together with the inhibition observed in the 
ABD/R-G domain, these data suggest that full-length ARHGAP10 is 
required as a link between ARF1 and Cdc42.
The inhibition mediated by the ARHGAP10 domains may be explained 
by sequestration of activated ARF1 and thus inhibition of ARF1, rather 
than a dominant-negative of ARHGAP10. To determine a role for 
ARHGAP10 more specifically, endogenous ARHGAP10 was depleted 
using shRNA. As hamster ARHGAP10 sequence is unknown, the effects 
of shRNA were monitored in MEFs, where the uptake of fluid is ARF1 
sensitive (Fig. 1b) and the ARHGAP10 sequence has been determined. 
The efficacy of shRNA was confirmed by monitoring the depletion 
of protein levels of an ARHGAP10 fragment when coexpressed with 
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Figure 6 Activated ARF1 is located at the plasma membrane and on fluid-
containing nascent endosomes. (a) IA2.2 cells transfected with ARF1–
GFP and GFP–ABD expression vectors as indicated were sequentially 
imaged using TIRF and wide-field illumination. ARF1–GFP and GFP–ABD 
appear enriched on the Golgi in the wide-field (inset), whereas in the 
same cells distinct punctate foci of these proteins are visible in the 
TIRF field. Cotransfection of cells with HA–ARF1T31N and ARF1 shRNA 
removes these foci from the plasma membrane. (b) Histogram showing 
the fraction of GFP–ABD transfected cells with punctate distribution on 
cotransfection with ARF1T31N or ARF1 shRNA. The error bars represent 
weighted mean ± s.e.m. (n = 45, 36, 42). (c) IA2.2 cells transfected 
with ARF1–GFP and RFP–ABD were imaged live using sequential TIRF 
illumination. The delay between acquisition of ARF1 and ABD images 
is 200 ms. Note that in merge of ARF1 and ABD images, all the ABD 
puncta colocalize with ARF1. A portion of merge (box) is magnified in 
e. (e) IA2.2 cells transfected with ARF1–GFP (left, green) or GFP–ABD 
(right, green) were pulsed with TMR–Dex (Fluid, red) for 40 s at 37 °C, 
washed, fixed and imaged. Insets show a magnified view of the region 
demarcated with a square, where there is extensive colocalization of the 
two colours. The scale bars in a, d and e represent 10 µm.
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Figure 7 ARF1 activation couples to Cdc42 dynamics at plasma 
membrane. (a) IA2.2 cells expressing Cdc42–GFP, without or with 
cotransfection of ARF1 shRNA were imaged at 37 °C under TIRF 
illumination to visualize distribution of single molecules of Cdc42 at the 
plasma membrane. The histogram shows that the mean residence time 
of Cdc42 (indicated by arrows) and the average number of molecules 
(± s.d.) shown in the inset, increase in ARF1 shRNA transfected cells. 
Data are from one experiment out of two with similar results, where 12 
cells in each condition were analysed. The asterisk indicates P  ≤0.006. 
(b) IA2.2 cells transfected with GFP–Cdc42L61 (green in merge) were 
pulsed with TMR–Dex (red in merge), fixed and imaged. The histogram 
shows the uptake of TMR–Dex in cells expressing GFP–Cdc42L61 
normalized to untransfected cells from a single experiment, repeated 
twice with similar results. The error bars represent weighted mean ± s.
e.m. (n = 50, 58). The asterisk represents P ≤0.002. (c) IA2.2 cells 
transfected with HA–ARF1Q71L either alone or with Cdc42N17 were 
assayed for FR–GPI uptake (FR), and processed for detection of HA–
ARF1Q71L and GFP. The histogram shows quantification of endocytosed 
Alexa568–Mov19 Fab fluorescence (normalized to surface FR–GPI 
levels) in cells expressing ARF1Q71L, cotransfected with GFP–Cdc42N17, 
or treated with Toxin B (1 μg ml–1 for 60 min), plotted as a ratio 
to uptake measured in untransfected (control) cells. The error bars 
represent weighted mean ± s.e.m.  (n = 60, 78, 73, 79). The single 
and double asterisks represent P ≤0.003 for the indicated comparisons. 
(d) In a model for ARF1-dependent regulation of endocytosis via GEEC 
pathway, ARF1 is activity is governed by a BFA-resistant GEF and a GAP 
of unknown identity (?). Activated ARF1 recruits ARHGAP10 to function 
as a RhoGAP for Cdc42, resulting in inactivation and release of Cdc42 
into cytosol. Activated Cdc42 regulates dynamic actin polymerization 
that leads to formation of endosomes via the GEEC pathway. However, 
persistent activation of Cdc42 (due to constitutively activated Cdc42 or 
loss of ARHGAP10-based RhoGAP activity) leads to a different type of 
actin architecture (see box), incompatible with endocytosis via the GEEC 
pathway. The scale bars in a, b and c represent 10 µm.
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shRNA (Fig. 5e), or by monitoring the effects on actin organization and 
Golgi morphology as described previously34 (Fig. 5d). In approximately 
60% of GFP-expressing cells, the shRNA resulted in alteration in Golgi 
morphology; fewer cells showed a perturbation of actin organization 
(approximately 30%). Consistent with this result, expression of shRNA 
against ARHGAP10 resulted in approximately 60% of the transfected cells 
exhibiting a detectable reduction in fluid uptake (Fig. 5f, g). These results 
implicate ARHGAP10 in uptake via the GEEC pathway, downstream of 
ARF1 activation, potentially coupling it with GAP activity for Cdc42.
Recruitment of ABD to the plasma membrane is sensitive to 
ARF1 activation
The involvement of ARF1 in endocytosis at the plasma membrane 
requires plasma membrane-localized activated ARF1. To observe the 
distribution of ARF1 at the plasma membrane, total internal reflection 
fluorescence microscopy (TIRFM) was used to report on distribution 
of fluorophores in the evanescent field in close proximity (~100 nm 
for 488nm illumination) to the plasma membane. TIRFM imaging of 
live cells expressing low levels of ARF1–GFP revealed relatively stable, 
punctate structures located at the plasma membrane (Fig. 6a and see 
Supplementary Information, Movie 1) that were resistant to treatment 
with BFA (see Supplementary Information, Fig. S5b).
To determine whether the recruitment of the ABD at the plasma mem-
brane depends on ARF1 activation, live cells expressing very low levels of 
GFP-tagged constructs of different ARHGAP10 domains were imaged 
using TIRFM (Fig. 6a and see Supplementary Information, Fig. S6a). Low 
levels of expression provided better contrast of detection in TIRFM and 
did not affect fluid uptake, therefore acting as non-perturbing report-
ers. Full-length ARHGAP10 was not detectably expressed in cells34, but 
similarly to ARF1–GFP, GFP–ABD appeared as relatively stable, punc-
tate structures at the plasma membrane (Fig. 6a). Although GFP–ABD 
structures were fewer in number than ARF1–GFP, they mimicked both 
the morphology and distribution of ARF1 puncta. Similar punctuate 
patterns were observed for ABD/R-G, which can bind to activated 
ARF1 and Cdc42, but the R-G domain (lacking ABD) was uniformly 
distributed (see Supplementary information, Fig. S6a). To determine 
whether ABD is a sensor of ARF1 activation, it was coexpressed with 
ARF1 shRNA or HA-tagged ARF1T31N (Fig. 6a). In both cases, GFP–
ABD was not recruited to the plasma membrane and appeared similar 
to cytosolic GFP9. Furthermore, RFP–ABD punctae colocalized with 
ARF1–GFP in the TIRFM field (Fig. 6c, d), but not with ARF6–GFP 
(see Supplementary Information, Fig. S6b–d).
These observations provide evidence for endogenous ARF1 activation 
and localization at or near the plasma membrane, and support the use of 
ABD as a reporter for endogenous ARF1 activation. The recruitment of 
ABD to activated ARF1 sites in the plasma membrane is consistent with the 
coupling of activated ARF1 to ARHGAP10 in the plasma membrane.
Activated ARF1 is located on early intermediates of the GEEC 
pathway
If ARF1 activity is required for endocytosis via the GEEC pathway, colo-
calization of activated ARF1 on nascent endocytic carriers of the GEEC 
pathway should be observed. For this purpose, cells were pulsed with 
TMR–Dex for short times (60 s) and imaged. A fraction of fluid-contain-
ing endosomes colocalized with GFP–ABD-labelled vesicles and tubules 
(Fig. 6e) and colocalization was also observed with ARF1–GFP (Fig. 6e). 
Newly formed fluid and FR–GPI containing endocytic carriers did not 
colocalize with coat components such as COPI (known to interact with 
ARF1 on Golgi and some endosomal membranes31), even in the presence 
of ARF1Q71L (see Supplementary information, Fig. S5d).
ARF1 influences Cdc42 dynamics on plasma membrane
To address the role of ARF1 in regulating Cdc42 dynamics at the plasma 
membrane, the recruitment of Cdc42 to the plasma membraned was 
monitored using live-cell TIRFM, both in control cells and after silenc-
ing endogenous ARF1 (Fig. 7a). The extent of recruitment, and plasma 
membrane residence time, of single molecules of Cdc42 are positively 
influenced by GTP-bound status of Cdc42 (ref. 9). Depletion of ARF1 
enhanced both the number of Cdc42 recruitment events and its resi-
dence time (Fig. 7a and see Supplementary Information, Movie 2), 
and formation of cortical spike-like structures (see Supplementary 
Information, Fig. S2e), consistent with activation of Cdc42 at the plasma 
membrane9,36,37. Furthermore, similarly to ARF1 silencing, overexpres-
sion of a constitutively active form of Cdc42 (Cdc42L61) led to reduction 
in fluid-phase uptake (Fig. 7b).
To determine whether the coupling of ARF1 activation and Cdc42 
dynamics can influence endocytosis via the GEEC pathway, GPI-
AP endocytosis was monitored in cells overexpressing ARF1Q71L. 
Coexpression of Cdc42N17 (a GTP-exchange deficient form4) or treat-
ment with Toxin B (an inhibitor of Rho GTPases) reverted the activated 
ARF1Q71L-mediated increase in GEEC endocytosis (Fig. 7c). These results 
provide evidence that ARF1 is part of the molecular machinery that 
regulates the GEEC pathway, upstream of Cdc42.
DIsCussIon
ARF1 has been extensively studied in COPI-coated vesicle formation at 
the Golgi38, and it is also involved in recruiting AP3 and COPI subunits to 
endosomal membrane buds in PC12 cells31,39. A recent report using a het-
erologously expressed sensor for activated ARFs detected BFA-insensitive 
sequential activation of ARF6 followed by ARF1 at sites of phagocytosis40.
Our data, using a variety of techniques including RNAi depletion, domi-
nant-negative inhibition and dominant-active activation, support a model 
(Fig. 7d) wherein activated ARF1 is directly and specifically involved in 
endocytosis via the Cdc42-regulated GEEC pathway at the cell surface.
There are several lines of evidence that support a role for ARHGAP10 
as the downstream effector of activated ARF1 at the plasma membrane, 
providing the critical GAP-activity necessary for Cdc42 cycling: first, 
activated ARF1 directly binds to ARHGAP10 (ref. 34) and silencing 
ARHGAP10 inhibits endocytosis via the GEEC pathway; second, ARF1-
binding fragments of ARHGAP10 (ABD) block ARF1Q71L-induced acti-
vation of the GEEC pathway, as well as the constitutive operation of this 
pathway; and third, ABD exhibits a dynamic punctate distribution at 
the plasma membrane colocalized with ARF1, and maintained by acti-
vated ARF1, as depletion of ARF1 or overexpression of ARF1T31N pre-
vents recruitment of the ABD domain. Although ABD serves as a specific 
reporter for ARF1 on the plasma membrane, ABD is also capable of inter-
acting with both ARF6 and ARF1 on intracellular structures — although 
much higher expression levels of ARF6 are required for visualizing the 
colocalization of ABD–RFP and ARF6 (see Supplementary Information, 
Fig. S6). This difference may arise due to differences in membrane com-
position at plasma membrane and endomembranes, such that association 
with ARF1 is more favoured at some regions on the plasma membrane. 
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These regions could mark the sites where endocytosis via GEECs is initi-
ated by enhancing the local cycling kinetics of Cdc42.
The coupling of ARF1 activation with a Cdc42–GAP activity is sup-
ported by the observation that depletion of ARF1 or ARF1T31N expression 
(data not shown) results in persistently activated Cdc42 at the plasma 
membrane, as assessed by single-molecule TIRFM. As expression of 
both GTP-binding and GTPase-deficient mutants of Cdc42 inhibit 
endocytosis via GEECs, these results support a role for ARF1-activa-
tion in dynamic cycling of Cdc42, required for endocytosis via GEECs. 
Activated Cdc42 is recruited to the plasma membrane and initiates actin 
polymerization, thereby promoting endocytosis via GEECs in an actin-
dependent mechanism9. This is reminiscent of ARF1–ARHGAP10 in 
actin-patch formation at the Golgi34. Likewise, it is possible that the 
ARF–ARHGAP10 interaction can also aid other endomembrane trans-
port processes, the involvement of these molecular interactions in intra-
cellular trafficking processes is not clear as yet.
The involvement of ARF1 in endocytosis demands a source of acti-
vated ARF1 and its effectors (GAPs and GEFs) at the plasma mem-
brane. Our data show that the GEF involved in ARF1 activation is BFA 
insensitive. Similar observations have been reported in studies on the 
uptake of FM4-64 in maize root-hair cells41 and phagocytosis in macro-
phages40, where endocytosis is blocked on overexpression of ARF1T31N, 
but not by BFA treatment. A recent report has shown that a BFA resistant 
ARF–GEF, GNL1 is required for selective internalization at the plasma 
membrane in Arabidopsis root-hair cells42. The BFA-insensitive GEF 
could be a member of ARNO–Cytohesin family43. However, expres-
sion of deletion mutants of ARNO failed to inhibit GPI-AP’s uptake 
(S.K., unpublished observations), suggesting the use of other GEF(s). 
Another regulator of dynamin-independent endocytic pathways is the 
CtBP1–BARS protein, which is reported to aid vesicle fission11. It is inter-
esting that the ARF1-specific GAP protein, ARFGAP1, interacts directly 
with BARS, and is hypothesized to function as a dynamin counterpart44. 
ARFGAP1 may provide a link for interaction of ARF1 based machinery 
with CtBP1–BARS.
These studies suggest that endocytosis via the GEEC pathway could 
be limited by the availability of activated ARF1 at the plasma membrane 
in a wide variety of cell lines, including a human cell line (S.K., unpub-
lished observations), and support a central role for ARF1 where it is 
necessary for endocytosis via GEECs, but do not exclude an ancillary 
role for ARF3 — ARFs have been reported to function in combination 
in specific trafficking processes22.
Activated ARF1 (detected by ABD-GFP staining) is also found on 
nascent endocytic structures that contain the fluid phase and have the 
characteristic tubular morphology of CLICs and GEECs5. However, at 
this time, we cannot determine whether ARF1 is derived directly from 
the cell surface or independently recruited to CLICs–GEECs, post-inter-
nalization. Thus, in addition to its role at the plasma membrane, ARF1 
may have other roles in the GEEC pathway. Endocytic carriers stimulated 
by expression of ARF1Q71L do not colocalize with COPI (β-COP) in fixed 
cells; ARF1 may recruit other endosomal coats onto GEECs, such as AP3 
on endosomes in PC12 cells39 or other molecules15. Overexpression of 
ARF1Q71L leads to peripheral distribution of FR endosomes, suggesting 
a role in post-endocytic trafficking as well.
ARF6 is also thought to regulate a clathrin and dynamin-independent 
endocytic pathway3,16. As ARF6 depletion or inhibition6 has no effect 
on uptake into GEECs, this argues that the ARF6- and Cdc42-regulated 
pathways are either distinct processes operating differentially in differ-
ent cell types, or that ARF6 could modify the ARF1–Cdc42-regulated 
pathway, post-internalization in some cell types.
In conclusion, we find that multiple proteins, which have a Golgi-
enriched steady-state distribution, are involved in regulating endocytosis 
via the dynamin-independent pinocytic (GEEC) pathway. In addition to 
ARF1, CtBP1–BARS and Cdc42 are both enriched in the Golgi11,45. The 
involvement of yet another central secretory traffic regulator, ARF1 in 
endocytosis, raises an interesting possibility that exocytosis and endocy-
tosis may be integrated for maintenance of plasma membrane homeos-
tasis2. In addition, our data suggest that this is likely to be accomplished 
by regulated spatial distribution of distinct ARF1 effectors, and will be 
a focus of future studies.
METHoDs
Cell culture, reagents, and plasmids. See Supplementary Information, 
Methods.
Synthesis of RNAi-resistant ARF1 and shRNA against ARF6 and ARHGAP10. 
RNAi-resistant ARF1 was generated by using a primer 5´-ATAGGCTTCAACG
TGGAAACGGTAGAGTACAAGAACATCAGCTTC-3´, where the nucleotide 
sequences corresponding to the ARF1 RNAi sequence used were altered as indi-
cated in bold type. This primer was used to amplify human ARF1–GFP using PCR. 
The resultant plasmid was sequenced verified before use. ARF6 shRNA (sequence 
corresponding to 307–327 nucleotides of human ARF6 coding sequence; 5´-
CCAGGAGCTGCACCGCATTAT-3´), was chosen as target sequence. This 
sequence is conserved in human, mouse and rat ARF6. The shRNA against this 
sequence was ligated into pGSUPER vector, as previously described46. A similar 
procedure was used for generation of ARHGAP10 shRNA. The sequence cho-
sen was conserved between human and mouse ARHGAP10 and corresponds to 
817–836 in human coding sequence (5´-GTCATTGTGCCTTCTGAGA-3´). For 
generation of mRFP–ABD, mRFP was obtained from plasmid mRFPpSETb using 
the primer 5´-ATAGGTACCACCGGTCGCCACCATGGCCTCCTCCGAG-3´. 
Following the RFP sequence, a 14 bp linker sequence was added such that mRFP 
sequence is flanked by AgeI and BglII enzyme sites. EGFP from pEGFPC2–ABD 
was replaced with mRFP, using these enzyme sites. All of the above mentioned 
constructs were used after confirmation of sequence following cloning.
Endocytic and exocytic assays and immunofluorescence microscopy. Endocytic 
and exocytic assays cells were carried out as previously described4 with minor 
modifications, as detailed in the Supplementary Information, Methods.
shRNA transfection and western blotting. shRNA in the pSUPER vector (ARF1) 
was transfected with a fixed ratio of vector carrying the shRNA sequence of 
interest or pSUPER vector alone (mock) with pEGFP-N1 (3:1, w/w) in 3 cm 
cover-slip dishes, to ensure cotransfection. Coexpression using this protocol was 
confirmed by measuring the reduction of protein target levels in GFP-expressing 
cells by using specific antibodies against the protein target. In all of the endo-
cytic experiments, shRNA was cotransfected with pEGFP-N1 for identification 
of transfected cells, unless otherwise mentioned. Cells transfected with shRNA 
directed against ARF6 in pG-SUPER vectors were identified by GFP coexpres-
sion. To biochemically measure protein depletion, cells were plated in 92 mm 
dishes and cotransfected with shRNA carrying vector or vector alone (control) 
with pEGFP-N1. Post-transfection, cells were allowed to grow for 60 h, harvested 
using trypsin–EDTA, and GFP-positive cells were sorted using FACS-Vantage SE 
(BD,  San Jose, CA). Approximately 30,000 sorted cells from each transfection 
were lysed and loaded on a 12% SDS–PAGE. Protein estimation was carried out 
after transfer of proteins on PVDF membranes and the regions corresponding 
to bands of interest on the membrane were cut and probed using anti-ARF1, 
anti-ARF6, anti-ARF3 or anti-actin antibodies. The band intensities were sub-
sequently quantified.
Imaging, image processing and quantification. Confocal microscopy was carried 
out on a Zeiss LSM 510 Meta imaging system (63× 1.4 NA; Zeiss, Jena, Germany) or 
Andor Spinning Disc confocal imaging system (60× 1.42 NA or 100× 1.4 NA, with 
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Ixon EMCCD; Andor Technologies,  Belfast, Ireland) using appropriate factory-set 
filters and dichroics for different fluorophores. Care was taken to avoid fluorophore 
saturation during acquisition. For quantitative imaging on spinning disc confocal 
microscope, laser powers and camera gains were maintained constant throughout 
the experiment. Images acquired using LSM (Zeiss) software or Revolution (Andor) 
software was converted into TIFF and analysed using Metamorph software. For 
live imaging, Nikon TE 2000 inverted system equipped with 100× oil objective 
(NA 1.45) and a cooled CCD cascade camera (Photometrics Inc, Tuscon, AZ) was 
used. For dual-colour live imaging, cell growth medium was changed to M1 with 
0.1% BSA and glucose, and the dishes containing cells were brought to tempera-
ture-controlled stage maintained at 37 °C. Images were collected using Metamorph 
acquisition software.
For quantification of uptake of endocytic tracers, images were obtained using 
20×, 0.75 NA objective on widefield microscope (Nikon TE300). The cells from 
different fields from each dish were defined as regions, and the integrated intensi-
ties inside the ‘regions’ were obtained using the ‘region measurement’ application 
of Metamorph. Average and s.d. of integrated intensities per cell from each dish 
was determined and plotted as weighted mean of these values, as described in 
statistical analysis section, unless otherwise stated. The number and intensity of 
endosomes formed in cells pulsed with TMR–Dex (1 mg ml–1) for 3 min at 37 °C 
were determined by imaging cells at 20 °C. Images were processed and the endo-
somes were identified, and total number of endosomes and associated intensity 
were calculated, as previously described4,6. Briefly, the images were processed for 
background correction using Metamorph and threshold using Multispot software, 
such that all the endosomes with intensity above the background were identified. 
The number of endosomes, area and integrated intensity per endosome were 
determined per cell using Multispot.
TIRF imaging was carried out exactly as previously described9. Cdc42 spots 
were defined as pixels with intensity values above autofluorescence and cor-
respond to single molecules of Cdc42–GFP according to criterion previously 
established criterion9. Note, bleaching of single GFP fluorophores occurs over 
a much longer period than measured for the Cdc42–GFP fluorophores. Only 
spots that make an appearance within the imaging duration (100 ms per frame, 
200 frames stream acquisition) were considered for quantification. The residence 
time of each spot was manually estimated by determining the number of frames 
it was visible. The data were binned and expressed as percentage of total number 
of dynamic spots tracked.
In all cases, images were analysed using Metamorph software and processed for 
presentation using Adobe Photoshop. Images are displayed at the same contrast-
settings for control and treated cells in all display items. The scale bar corresponds 
to 10 µm, unless otherwise specified.
Statistical analysis. The values plotted are weighted mean, µx, obtained from at least 
two different dishes in each experiment, calculated using the following formula
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unless otherwise specified. Minimum number of cells (n) quantified from an 
individual dish is indicated in the figure legends. Statistical significance was meas-
ured using unpaired, two-tail distribution, Student’s it-test. Unless specifically 
mentioned, the P values were <0.001 in all cases reported. Each experiment was 
repeated three or more times with similar results, unless otherwise stated.
Note: Supplementary Information is available on the Nature Cell Biology website.
ACKNOWLEDGMENTS
We thank M. Kalia and B. Srinag for help with biochemistry, H. Krishnamurthy and 
Wellcome Trust-aided imaging and flow-cytometry facility at NCBS for help with 
confocal imaging and sorting transfected cells. We are indebted to: G. D. Gupta 
for making ARF6 shRNA; R. Alexander for ARF1 RNAi resistant and mRFP–ABD 
vectors; N, Sabu for ARHGAP10 shRNA; J. Gruenberg for GFP-tagged wild-type 
ARF1 and ARF1T31N plasmids; S.G. Ferguson for HA-tagged wild-type ARF1, 
ARF1T31N and ARF1Q71L constructs; P. Chavrier for GFP–ARHGAP10 domains; 
R. A. Kahn for ARF1, ARF3, ARF4 and ARF5 shRNA plasmids; R. Vishwakarma 
for fluorescent folate analogues; S. Bourgoin for ARF6-specific antibodies; and 
R. E. for C6-LacCer. We thank other members of the Mayor Laboratory and NCBS 
for generous support and encouragement. S.K. is supported by a pre-doctoral 
fellowship from Council of Scientific and Industrial Research (Government of 
India). Work in S.M.’s laboratory is supported by intramural funds from NCBS, and 
a J. C. Bose fellowship. 
AUTHOR CONTRIBUTIONS
S.K. executed and analysed all experiments.  S.K. and S.M. planned all experiments 
and wrote the manuscript.
Published online at http://www.nature.com/naturecellbiology/Reprints 
and permissions information is available online at http://npg.nature.com/
reprintsandpermissions
1. Conner, S. D. & Schmid, S. L. Regulated portals of entry into the cell. Nature 422, 
37–44 (2003).
2. Kirkham, M. & Parton, R. G. Clathrin-independent endocytosis: new insights into 
caveolae and non-caveolar lipid raft carriers. Biochim. Biophys. Acta 1746, 350–363 
(2005).
3. Mayor, S. & Pagano, R. E. Pathways of clathrin-independent endocytosis. Nature Rev. 
Mol. Cell Biol. 8, 603–612 (2007).
4. Sabharanjak, S., Sharma, P., Parton, R. G. & Mayor, S. GPI-anchored proteins are 
delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent 
pinocytic pathway. Dev. Cell 2, 411–423 (2002).
5. Kirkham, M. et al. Ultrastructural identification of uncoated caveolin-independent early 
endocytic vehicles. J. Cell Biol. 168, 465–476 (2005).
6. Kalia, M. et al. Arf6-independent GPI-anchored protein-enriched early endosomal com-
partments fuse with sorting endosomes via a Rab5/phosphatidylinositol-3´-kinase-
dependent machinery. Mol. Biol. Cell 17, 3689–3704 (2006).
7. Guha, A., Sriram, V., Krishnan, K. S. & Mayor, S. Shibire mutations reveal distinct 
dynamin-independent and -dependent endocytic pathways in primary cultures of 
Drosophila hemocytes. J. Cell Sci. 116, 3373–3386 (2003).
8. Gauthier, N. C. et al. Helicobacter pylori VacA cytotoxin: a probe for a clathrin-independ-
ent and Cdc42-dependent pinocytic pathway routed to late endosomes. Mol. Biol. Cell 
16, 4852–4866 (2005).
9. Chadda, R. et al. Cholesterol-sensitive Cdc42 activation regulates actin polymerization 
for endocytosis via the GEEC pathway. Traffic 8, 702–717 (2007).
10. Glebov, O. O., Bright, N. A. & Nichols, B. J. Flotillin-1 defines a clathrin-independent 
endocytic pathway in mammalian cells. Nature Cell Biol. 8, 46–54 (2006).
11. Bonazzi, M. et al. CtBP3/BARS drives membrane fission in dynamin-independent 
transport pathways. Nature Cell Biol. 7, 570–580 (2005).
12. Sabharanjak, S. & Mayor, S. Folate receptor endocytosis and trafficking. Adv. Drug 
Deliv. Rev. 56, 1099–1109 (2004).
13. D´Souza-Schorey, C. & Chavrier, P. ARF proteins: roles in membrane traffic and beyond. 
Nature Rev. Mol. Cell Biol. 7, 347–358 (2006).
14. Zhang, C. J. et al. Expression of a dominant allele of human ARF1 inhibits membrane 
traffic in vivo. J. Cell Biol. 124, 289–300 (1994).
15. Nie, Z., Hirsch, D. S. & Randazzo, P. A. Arf and its many interactors. Curr. Opin. Cell 
Biol. 15, 396–404 (2003).
16. Naslavsky, N., Weigert, R. & Donaldson, J. G. Convergence of non-clathrin- and clathrin-
derived endosomes involves Arf6 inactivation and changes in phosphoinositides. Mol. 
Biol. Cell 14, 417–431 (2003).
17. Tanabe, K. et al. A novel GTPase-activating protein for ARF6 directly interacts with 
clathrin and regulates clathrin-dependent endocytosis. Mol. Biol. Cell 16, 1617–1628 
(2005).
18. Paleotti, O. et al. The small G-protein Arf6GTP recruits the AP-2 adaptor complex to 
membranes. J. Biol. Chem. 280, 21661–21666 (2005).
19. Vasudevan, C. et al. The distribution and translocation of the G protein ADP-ribosylation 
factor 1 in live cells is determined by its GTPase activity. J. Cell Sci. 111, 1277–1285 
(1998).
20. Dascher, C. & Balch, W. E. Dominant inhibitory mutants of ARF1 block endoplasmic 
reticulum to Golgi transport and trigger disassembly of the Golgi apparatus. J. Biol. 
Chem. 269, 1437–1448 (1994).
21. Lamaze, C. et al. Interleukin 2 receptors and detergent-resistant membrane domains 
define a clathrin-independent endocytic pathway. Mol. Cell 7, 661–671 (2001).
22. Volpicelli-Daley, L. A., Li, Y., Zhang, C. J. & Kahn, R. A. Isoform-selective effects of 
the depletion of ADP-ribosylation factors 1-5 on membrane traffic. Mol. Biol. Cell 16, 
4495–4508 (2005).
23. Macia, E., Chabre, M. & Franco, M. Specificities for the small G proteins ARF1 and 
ARF6 of the guanine nucleotide exchange factors ARNO and EFA6. J. Biol. Chem. 276, 
24925–24930 (2001).
24. Shen, X. et al. Association of brefeldin A-inhibited guanine nucleotide-exchange protein 
2 (BIG2) with recycling endosomes during transferrin uptake. Proc. Natl. Acad Sci. 
USA 103, 2635–2640 (2006).
25. Choudhury, A., Marks, D. L., Proctor, K. M., Gould, G. W. & Pagano, R. E. Regulation 
of caveolar endocytosis by syntaxin 6-dependent delivery of membrane components to 
the cell surface. Nature Cell Biol. 8, 317–328 (2006).
40  nature cell biology volume10|number1|JAnuArY2008
© 2008 Nature Publishing Group 
 
A RT I C L E S
26. Ellis, M. A., Miedel, M. T., Guerriero, C. J. & Weisz, O. A. ADP-ribosylation factor 1-
independent protein sorting and export from the trans-Golgi network. J. Biol. Chem. 
279, 52735–52743 (2004).
27. Yahara, N., Ueda, T., Sato, K. & Nakano, A. Multiple roles of Arf1 GTPase in the yeast 
exocytic and endocytic pathways. Mol. Biol. Cell 12, 221–238 (2001).
28. Riezman, H. Endocytosis in yeast: several of the yeast secretory mutants are defective 
in endocytosis. Cell 40, 1001–1009 (1985).
29. Doms, R. W., Russ, G. & Yewdell, J. W. Brefeldin A redistributes resident and itinerant 
Golgi proteins to the endoplasmic reticulum. J. Cell Biol. 109, 61–72 (1989).
30. Donaldson, J. G., Finazzi, D. & Klausner, R. D. Brefeldin A inhibits Golgi membrane-
catalysed exchange of guanine nucleotide onto ARF protein. Nature 360, 350–352 
(1992).
31. Gu, F. & Gruenberg, J. ARF1 regulates pH-dependent COP functions in the early endo-
cytic pathway. J. Biol. Chem. 275, 8154–8160 (2000).
32. Prydz, K., Hansen, S. H., Sandvig, K. & van Deurs, B. Effects of brefeldin A on endo-
cytosis, transcytosis and transport to the Golgi complex in polarized MDCK cells. J. 
Cell Biol. 119, 259–272 (1992).
33. Shin, H. W., Morinaga, N., Noda, M. & Nakayama, K. BIG2, a guanine nucleotide 
exchange factor for ADP-ribosylation factors: its localization to recycling endosomes 
and implication in the endosome integrity. Mol. Biol. Cell 15, 5283–5294 (2004).
34. Dubois, T. et al. Golgi-localized GAP for Cdc42 functions downstream of ARF1 to control 
Arp2/3 complex and F-actin dynamics. Nature Cell Biol. 7, 353–364 (2005).
35. Sousa, S. et al. ARHGAP10 is necessary for alpha-catenin recruitment at adherens 
junctions and for Listeria invasion. Nature Cell Biol. 7, 954–960 (2005).
36. Hall, A. Rho GTPases and the actin cytoskeleton. Science 279, 509–514 (1998).
37. Yang, L., Wang, L. & Zheng, Y. Gene targeting of Cdc42 and Cdc42GAP affirms the criti-
cal involvement of Cdc42 in filopodia induction, directed migration, and proliferation 
in primary mouse embryonic fibroblasts. Mol. Biol. Cell 17, 4675– 4685 (2006).
38. Spang, A. ARF1 regulatory factors and COPI vesicle formation. Curr. Opin. Cell Biol. 
14, 423–427 (2002).
39. Faundez, V., Horng, J. T. & Kelly, R. B. A function for the AP3 coat complex in synaptic 
vesicle formation from endosomes. Cell 93, 423–432 (1998).
40. Beemiller, P., Hoppe, A. D. & Swanson, J. A. A phosphatidylinositol-3-kinase-dependent 
signal transition regulates ARF1 and ARF6 during Fcγ receptor-mediated phagocytosis. 
PLoS Biol 4, e162 (2006).
41. Xu, J. & Scheres, B. Dissection of Arabidopsis ADP-RIBOSYLATION FACTOR 1 function 
in epidermal cell polarity. Plant Cell 17, 525–536 (2005).
42. Teh, O.K. & Moore, I.  An Arf–GEF acting at the Golgi and in selective endocytosis in 
polarized plant cells. Nature  448, 493–496 (2007).
43. Chardin, P. et al. A human exchange factor for Arf contains Sec7- and pleckstrin homol-
ogy domains. Nature 384, 481–484 (1996).
43. Yang, J. S. et al. Key components of the fission machinery are interchangeable. Nature 
Cell Biol. 8, 1376–1382 (2006).
44. Erickson, J. W., Zhang, C., Kahn, R. A., Evans, T. & Cerione, R. A. Mammalian Cdc42 
is a brefeldin A-sensitive component of the Golgi apparatus. J. Biol. Chem. 271, 
26850–26854 (1996).
45. Kojima, S., Vignjevic, D. & Borisy, G. G. Improved silencing vector co-expressing GFP 
and small hairpin RNA. Biotechniques 36, 74–79 (2004).
nature cell biology volume10|number1|JAnuArY2008 41  
© 2008 Nature Publishing Group 
 
© 2008 Nature Publishing Group 
 
S U P P L E M E N TA RY  I N F O R M AT I O N
WWW.NATURE.COM/NATURECELLBIOLOGY 1
Figure S1 Dominant negative mutants of ARF1 do not affect clathrin-
independent but dynamin-dependent endocytic uptake. (a-c) ARF1-T31N 
expression does not affect caveolar uptake. (a) IA2.2 cells transfected with 
RFP alone (control) or along with HA-tagged ARF1-T31N for 18h were pulsed 
with Alexa647-Dex and C6-LacCer, washed and processed for imaging. Note 
uptake of C6-LacCer is unaffected in cells expressing ARF1-T31N, whereas, 
Alexa647-Dex internalization is inhibited. (b) IA2.2 cells, transfected with 
ARF1-T31N as above were labeled with C6-LacCer, excess label was washed 
off, and the cells were immediately taken for imaging. Note surface labeling 
of C6-LacCer is unaffected by ARF1-T31N overexpression, marked with 
asterisk (*). (c) Histogram shows the quantification of the extent of fluid-
phase uptake and C6-LacCer, normalized to control, RFP-transfected cells. 
This experiment was repeated twice with similar results. Bars are weighted 
mean +/- SEM. n> 25. d) Uptake of IL2R-β is not affected by inhibition 
of ARF1 activity: IA2.2 cells cotransfected with IL2R-β and either ARF1-
T31N-GFP (left panels) or eGFP-N1 (right panels: control) were labeled 
with Alexa568 anti-IL2R-β on ice for 1h, washed and chased in presence of 
Alexa647-Dex (fluid) at 37°C for 3min, washed and fixed. The images show 
the single confocal section in middle plane of the cells. The insets in IL2R-β 
image show the lowermost section depicting the surface levels of IL2-β in 
corresponding cells. Note that in cells transfected with ARF1-T31N, while 
fluid uptake is reduced, anti-IL2R-β uptake is unaffected.
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Figure S2  Dominant-negative ARF1 expression inhibits endocytosis via 
GEEC in multiple cell types, and also blocks exocytosis of GPI-APs. (a) 
ARF1-T31N expression inhibits fluid-phase and GPI-AP endocytosis in 
different cell type. BHKs transfected with ARF1-T31N for 20h, were pulsed 
with TMR-Dex or Alexa647Mov19 for 5min and processed for imaging. Single 
confocal planes from a stack of images show the extent of internalized cargo. 
Note fluid-phase uptake (upper panel) and FR-GPI uptake (in cells with 
comparable surface FR-GPI expression), are inhibited in transfected cells 
(*). > 60% of ARF1-T31N transfected cells show obvious downregulation of 
fluid-phase and FR-GPI uptake. (b) GPI-AP exocytosis is inhibited by ARF1-
T31N expression. IA2.2 cells were transiently transfected with CFP-GPI, 
either alone (-) or with ARF1-T31N (+), for 12h and shifted to 20°C, and 
incubated for additional 8h in HEPES-buffered growth medium. Surface 
levels of CFP-GPI were monitored before (20°C) and after chase for 1h at 
37°C in presence of cycloheximide (37°C). Histogram shows quantification 
of anti-CFP fluorescence detected at the cell surface normalized to total CFP 
expression per cell. Bars represent weighted mean from two independent 
experiments +/- SEM. n>35. This experiment was repeated twice with similar 
results. While the level of total CFP-GPI was similar, ARF1-T31N reduces 
net CFP-GPI secretion (compare surface levels of CFP-GPI before and after 
1h 37°C chase, with and without ARF1-T31N expression, respectively). 
c-e) Modulation of ARF1 levels and activity affect steady state cell surface 
levels of TfR and FR-GPI. IA2.2 cells transfected with ARF1-T31N for 16h 
or ARF1 shRNA for 62h, were incubated with saturating amounts of Cy5-
labelled Okt9 or Cy5-labelled Mov19 at 4°C for 1h, fixed and imaged. Cells 
expressing the indicated constructs (upper panels) exhibit altered receptor 
levels (lower panels, transfected cells outlined). (d) Histogram shows surface 
levels of receptors in transfected and control cells, normalized to control. 
Bars represent weighted mean from two independent experiments +/- SEM. 
n>75. (e) Cells transfected with ARF1 shRNA to deplete ARF1 levels show 
more spikes-like, filopodial structures compared to cells transfected with a 
control vector. 
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Figure S3. Depletion of ARF1 affects number and amount of endocytosed 
probe in GEECs whereas depletion of ARF6 is without any effect. (a-c) Effect 
of ARF1-depletion on endosomal parameters: Control and ARF1 shRNA-
transfected IA2.2 cells were pulsed with TMR-Dex for 3min at 37°C, fixed 
and imaged at high magnification and resolution (a; 60X, 1.4NA). Endosomes 
were identified and counted (Methods).  Histograms show the average 
integrated fluid uptake per cell normalized to that measured in control cells 
(Left histogram, pvalue, 0.003) and average number of fluid endosomes per 
cell (right histogram). Each bar represents average value +/- SD, n>15.  Graph 
shows the distribution of endosomes with respect to area (b; no. of pixels) and 
fluorescence intensities of endosomes (c) identified as above in control and 
ARF1-depleted cells. The number of endosomes is normalized to the total 
number of endosomes in each condition. Insets represent total fraction of 
endosomes present in the indicated bins. Note in ARF1-depleted cells while 
the net number and total uptake is lower (histogram in a), the shape of the 
endosomal population in terms of range of sizes (b; area) is almost identical to 
the control cells. There is a small difference in the fraction of very low (peak 
endosomal values in c) and very high intensity endosomes (inset in c). (d-f) 
Effect of ARF6-depletion: To examine the role of ARF6 in endocytosis via 
GEECs, IA2.2 cells were transfected with ARF6 shRNA in pGSUPER vector 
for 60h and processed for immunofluorescence (d, Top panel) or western blot 
(e) for assessing the extent of reduction of ARF6 protein, or assessed for their 
ability to endocytose FR-GPI (a, middle panel) or the fluid phase (a, bottom 
panel) by pulsing with PLR or TMR-Dex, respectively for 10min. Left panels in 
(d) show GFP-expression in cells transfected with ARF6 shRNA; corresponding 
cells are outlined in right panels in (d).  Histogram (f) shows the quantification 
of uptake of fluid-phase and FR-GPI in control and ARF6-depleted cells where 
endocytosed probe fluorescence is normalized to that measured in control 
cells. PLR-uptake is normalized to FR-GPI surface levels in each cell. Bars 
represent weighted mean from two independent experiments +/- SEM. n>85.
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Figure S4. Uptake into GEECs is insensitive to depletion of ARF4 and 
ARF5. (a) IA2.2 cells were transfected with either ARF4 shRNA or 
ARF5shRNA (upper panels) or along with ARF1 shRNA (lower panels) 
were stained for βCOP. Transfected cells were identified with GFP 
expression (corresponding images not shown). Note that while cell 
expressing ARF1 and ARF4 shRNAs (lower middle panel) has dispersed 
staining of βCOP, cells expressing ARF1 and ARF5 shRNAs have large 
cytoplasmic βCOP-containing inclusion like structures. This phenotype 
is seen in >70% of transfected cells, n>25. (b) IA2.2 cells were co 
transfected with eGFP-N1 with vector (control) or ARF1 or ARF4 or ARF5 
shRNAs and were pulsed with TMR-Dex for 5min, washed, fixed and 
imaged. The images show fluid uptake (lower panels) in cells transfected 
with shRNAs (upper panels). Histogram in (c) shows quantitation of 
fluid uptake in indicated expression backgrounds. Each bar represents 
weighted mean of average intensities from two independent experiments, 
normalized to the control, +/- SEM. 
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Figure S5. Effects of Brefeldin A and ARHGAP10 or ARF1-Q71L expression 
on endocytosis, ARF1-localization, and COPI localization. (a-b) Brefeldin A-
treatment enhances endocytosis via the GEEC pathway, and does not affect 
plasma membrane ARF1 localization. IA2.2 cells were treated with 20µg/ml 
BFA for 60min and pulsed with PLF, TMR-Dex and Alexa647-Tf during the last 
10min (a). After termination of pulse with washing, cells were processed for live 
imaging (Methods). Arrowheads in merge of fluid (green), FR-GPI (red) and TfR 
(blue) show endosomes of GEEC pathway, which are devoid of endocytosed TfR 
in control and treated cells. Note while the number and extent of endocytosis 
in BFA-treated cells in enhanced (quantification in Fig.4b), the endosomes still 
remain separate from endocytosed TfR, consistent with their identity as GEECs. 
Separately, IA2.2 cell transfected with ARF1-GFP was imaged live under TIRF 
and widefield (WF) illumination sequentially with a lag of 200msec (b).  The 
images are snapshots from a time course of BFA treatment on microscope 
stage. Note that after BFA treatment, while distribution on Golgi is altered 
drastically (WF), at PM, the punctate structures that mark sites of activated 
ARF1 remain unaltered. The overall levels of ARF1 in TIRF normalized to 
widefield increases marginally (data not shown). (c) Effects of BFA treatment, 
overexpression of ARHGAP10 mutants and ARF1-Q71L on TfR uptake. IA2.2 
cells were pulsed with Alexa568-Tf for the 10min. Surface Tf was removed and 
cell surface TfR levels were measured using ice labeling with Cy5-Okt9. The 
top histogram shows the ratio of Tf uptake in treated (BFA; 20µg/ml, 1h) and 
untreated (control) cells normalized to surface receptor expression in each 
cell, and plotted as a ratio of the uptake in control cells. Data are weighted 
mean from two independent experiments +/- SEM. n>150. In the middle 
histogram, IA2.2 cells transfected with cDNAs expressing indicated constructs 
for 16h were pulsed with Tf and uptake was quantified as above; the ratio of 
Tf uptake and surface receptor expression per cell in transfected cells was 
normalized to that measured in control cells. Data are weighted mean from two 
independent experiments +/- SEM. n>35. In the bottom histogram, IA2.2 cells 
transfected with pEGFP-N1 alone or with ARF1-Q71L for 16h were pulsed 
with Tf as above and the extent of Tf-uptake quantified. Data in histogram is 
weighted mean of average from two experiments, +/-SEM.  n>70. All of the 
above-mentioned experiments were repeated twice with similar results. (d) 
ARF1-generated GEECs do not co-localize with COPI. CHO cells transfected 
with GFP alone (Control) or with HA-ARF1-Q71L were pulsed with Cy3-MoV19 
Fabs for 5min, surface fluorescence was removed and cells were processed for 
immunofluorescence and imaged on a confocal microscope. Single confocal 
plane from a stack of images are shown where peripheral endosomes formed 
in presence or absence of ARF1-Q71L are clearly visualized. These structures 
do not co-localize with β-COP staining which is prominently visualized on the 
perinuclear vesicular structures in other confocal planes (data not shown).
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Figure S6. ABD domain of ARHGAP10 and activation of ARF1 is required 
for the localization of ARHGAP10 at the PM. (a) IA2.2 cells transfected with 
GFP-ABD, GFP-ABD/R-G, or GFP-R-G domains of ARHGAP10 (see Fig.5a) 
alone (top panels) or along with ARF1-T31N (bottom panels) were imaged 
in TIRF field. Note only ABD-containing domains are recruited to the cell 
surface in a punctate distribution. This recruitment is sensitive to ARF1 
activity since it is inhibited by co-expression of ARF1-T31N. (b) IA2.2 cells 
co-transfected with RFP-ABD along with ARF1-GFP (left panel) or ARF6-GFP 
(middle and right panels) were imaged using confocal microscopy. Each image 
represents merge of single confocal plane showing ARF1 (green) and ABD 
(red) distribution. Insets are magnified regions demarcated with square in 
corresponding source image. Note that while most ABD structures colocalize 
with ARF1, the colocalization with ARF6 is seen only at high expression levels 
of ARF6 (right panel), a scenario where still fraction of ABD is independent of 
ARF6, marking a perinuclear Golgi-like structure. n>20. This experiment was 
repeated twice with similar results. (c-f) IA2.2 cells cotransfeced with ARF6-
GFP and RFP-ABD were imaged live under TIRF illumination. Note that the 
overall distribution of ABD is distinct from ARF6. Insets in (c) and the panels 
in (e) are magnified from the regions marked with square in “merge” panel in 
(c). (f) The distribution of ABD at or near PM is not sensitive to ARF6 activity. 
Cells transfected with ABD alone (left panel) or cotransfected with HA-ARF6-
T37N were imaged using TIRF and wide-field illumination. The distribution of 
ABD at the PM is unaltered upon co-expression of ARF6-T37N. Insets show 
corresponding whole-cell widefield images. n>25. 
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Figure S7 Western blots used in the study. (a), (b), (c) represent the blots 
obtained from three independent experiments respectively, used in quantitation 
of ARF1 and ARF3 depletion in Fig.2b. Western blotting was carried out as 
described in methods. In all blots, first lane represents vector transfected cells 
(control), second lane and third lane represent lysates from cells transfected with 
ARF1 shRNA and ARF3 shRNA respectively. Corresponding actin levels (from 
the respective lysates in the same membrane) are shown immediately below the 
ARF lanes. Blot in (d) shows membrane probed for ARF6 in control and ARF6 
shRNA transfected cells and is original of the blot used in supplementary fig.
S3e. (e) represents the original of the blot used in Fig.2e. Blots shown in (f) 
are antibody-specificity controls, for ARF3 and ARF1 antibodies respectively. 
Both antibodies were found to detect single bands when used to probe control 
cell lysate using mentioned procedure (Methods). ARF1 antibody (Affinity 
Bioreagents, detects ARFs, MA3-060, generated for recombinant human ARF1) 
also detects overexpression of ARF1-GFP (Fig.3c) in an expression-dependent 
manner in immunofluorescence in CHO cells (data not shown) and is sensitive 
to reduction in ARF1 levels by shRNA. Anti-ARF3 antibody 4,5 (BD transduction 
laboratories, catalogue no.610785, generated for human ARF3) similarly 
detects single band in control cell lysates. Polyclonal anti-ARF6 antibody was 
kind gift of Dr. Sylvain Bourgoin (University of Alberta, Canada). All primary 
antibodies were used at a dilution of 1:100 and rabbit Anti-actin (Sigma 
Chemicals, A5060) was used at 1:1000 in 1% blotto in TTBS solution. HRP-
conjugated secondary antibodies (Jackson Immunoresearch) were used at a 
dilution of 1:5000). All the blots are presented in original, non-processed forms. 
For quantitation from (a,b,c), The scanned images were inverted using Adobe 
PhotoshopTM   , background subtracted and quantitated using MetamorphTM  
software. After obtaining per band intensity, the quantitations were carried out 
as described in Fig.2b legends.
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SUPPLEMENTARY MOVIE LEGENDS
Movie 1 Dynamics of ARF1-GFP (right) and GFP-ABD (left) on PM. CHO cells expressing very low levels of GFP-tagged proteins were imaged using TIRF 
microscopy, with 100msec exposure time and stream acquisition (10 frames/sec). Playback rate is 1.6 times faster than acquisition rate. Scale bar 
represents 10μm.
Movie 2 Dynamics of Cdc42 in the TIRF field in cells transfected with control vector (left) or with shRNA for ARF1. CHO cells expressing low levels 
of Cdc42-GFP were imaged using TIRF microscopy, with 100msec exposure time and stream acquisition (10frames /sec). Playback rate is same as the 
acquisition rate. Scale bar represents 10μm.
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Supplementary Text for Kumari and Mayor 
Supplementary Materials and Methods 
Materials: 
Chemicals, inhibitors and reagents were purchased from Sigma Chemicals Co. (St. Louis, 
MO), unless otherwise specified. TMR-Dex and amine-reactive fluorophores were 
purchased form Molecular probes (Eugene, OR).  Fluorophores were tagged to different 
proteins according to manufacturer’s instructions, and optimal dye to protein ratios 
obtained.  Fluorescent folate analogs N?-pteroyl-N?-(4’-fluorescein-thiocarbamoyl)-L-lysine 
(PLF) or N?-pteroyl-N?-(4’- lissamine rhodamine-thiocarbamoyl)-L-lysine (PLR) were 
synthesized by Dr. Ram Vishwakarma (NII, New Delhi) and was used at 40nM and 200nM, 
respectively, as described previously 
1
. N- (4, 4-difluoro-5, 7-dimethyl-4-bora-3a, 4a-diaza-
s-indacene-3-pentanoyl (BODIPY)-lactosylceramide (C6-LacCer) was kind gift from Dr. 
Richard E. Pagano (Mayo Clinic and Foundation, Rochester). HRP and TMB were 
purchased from Bangalore Genei (Bangalore, India).  
Cells and transfection: 
CHO cells or CHO cells stably expressing FR-GPI and human TfR (IA2.2 cells) were used 
for most of endocytic assays, as before 
2
. CHO cells were grown in HF-12 (HiMEDIA, 
Mumbai, India; CHO) while others (MEF, BHK) in DMEM, both containing NaHCO3, 
100?g/ml penicillin, streptomycin and supplemented with 10% FBS (GibcoBRL, Rockville, 
MD). Cells were transfected with different DNA constructs using FuGENE6 (Roche 
Diagnostics, GmbH Deutschland) according to manufacturer’s protocol. For transfections in 
MEFs, Effectene (Quiagen) was used. In cotransfection studies, DNA ratios were optimized 
to obtain coexpression of expressed proteins, and independently confirmed by 
© 2008 Nature Publishing Group 
 
immunofluorescence. Endocytic assays were carried 18-20 hours following transfection, 
unless otherwise indicated. Cell health was assessed using Trypan-blue exclusion and in all 
cases, transfected cells were indistinguishable from untransfected cells or control cells; 
>98% of cells excluded Trypan-blue regardless of the transfection employed (data not 
shown). In the images shown in supplementary figures, Scale bar represents 10μm, unless 
otherwise specified. 
Antibodies: 
Anti-HA mouse monoclonal antibody (6E2) and anti-V5 antibodies [Cell Signaling 
Technology (Beverly, MA)], anti-actin antibody (Sigma Chemical Co.), anti-ARF3 
monoclonal antibody [BD Transduction laboratories (San Diego, CA)] were used for 
western blotting and immunofluorescence as indicated. Anti-ARF6 rabbit polyclonal serum 
was a kind gift of Dr. Sylvain Bourgoin (University of Alberta, Canada); anti-ARF1 
antibody was a generous gift of Affinity Bioreagents (Golden, Co, USA). Fab fragments of 
anti-GFP and anti-FR MoV19 monoclonal antibodies generated using papain digestion 
subsequently fluorescently labeled and were used for monovalent receptor binding for 
endocytosis assays as described 
2
. Anti-TfR monoclonal antibody was purified from mouse 
hybridoma, OKT9 (National Centre for Cell Science, Pune, India). Anti- IL2-? monoclonal 
antibody (561) was kind gift of Dr. A. Dautry-Varsat (Institut Pateur, France). 
Plasmids: 
ARF1-GFP WT and dominant negative (T31N mutant) constructs were obtained from Dr. 
J. Gruenberg (University of Geneva). HA–tagged ARF1-WT, Q71L and T31N 
expressing constructs were obtained from Dr. Ferguson (Robarts Cell Biology Research 
Institute, Ontario, Canada). GFP-ARHGAP10 and related constructs, and ARF1, ARF3, 
ARF4 and ARF5 specific shRNA were provided by were kindly provided by Dr. Philip 
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Chavrier (Institut Curie, France), and Dr. Richard A. Kahn (Emory University), 
respectively. V5-tagged N-terminal fragment of ARHGAP10 used for assessing shRNA-
mediated depletion were obtained from Dr. Pascale Cossart (Institut Pasteur, France). 
IL2-? expression plasmid was was kind gift of Dr. A. Dautry-Varsat (Institut Pateur, 
France). GFP and HA-tagged ARF6 constructs were provided by Dr. J. Donaldson 
(National Institutes of Health, USA). 
Table 1 
  ShRNA target          Sequence (5’-3’) 
 
1. 
 
ARF1 
3
 
                          
ACCGTGGAGTACAAGAACA 
 
 
2. 
 
ARF1
3
 
                          
TGACAGAGAGCGTGTGAAC       
 
 
3.  
 
ARF3 
3
 
                                    
ACAGGATCTGCCTAATGCT 
 
 
4. 
 
ARF4 
3
 
  
TCTGGTAGATGAATTGAGA 
 
 
5. 
 
ARF5 
3
 
 
TCTGCTGATGAACTCCAGA 
 
 
6. 
 
ARF6 (this 
study) 
 
CCAGGAGCTGCACCGCATTAT 
 
7. 
 
ARHGAP10 
(this study) 
 
GTCATTGTGCCTTCTGAGA 
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Endocytic and exocytic assays and immunofluorescence: 
Endocytic and exocytic assays cells were carried out as described 
2
 with minor 
modifications. Briefly, endocytosis of FR-GPI or TfR was monitored by labeling cells with 
fluorescently tagged Mov19 Fabs (5μg/ml) or Tf (10μg/ml) incubated at 37°C for indicated 
times. The pulse was terminated by cooling cells on ice and washing with chilled HEPES-
buffered isotonic buffer (M1:140mM NaCl, 20mM HEPES, 1mM CaCl2, 1mM MgCl2, 
5mM KCl, pH 7.4). To remove surface fluorescence, cells were treated with PI-PLC 
(50μg/ml, 1h; GPI-APs) or with ascorbate buffer (160mM sodium ascorbate, 40mM 
ascorbic acid, 1mM MgCl2, 1mM CaCl2, pH 4.5; Tf) at 4°C and subsequently fixed with 
2% paraformaldehyde for 15min. Similarly, for fluid-phase and CTx uptake, cells were 
incubated with 1mg/ml fluorescently-labeled dextran or 1μg/ml CTx at 37°C. C6-LacCer 
endocytosis was monitored by surface labeling cells with C6-LacCer. C6-LacCer was 
(2.6mM in ethanol) dissolved in 0.15% defatted BSA to achieve a concentration of 100μM. 
The BSA-lipid complexes was dialyzed against PBS at 37ºC for 20min to remove ethanol 
and used for endocytosis assays. IA2.2 cells pre-incubated in serum-free medium for 1h, 
and prior to incubation with 200nM BSA-lipid complexes on ice for 20min. Subsequent to 
washing, cells were chased at 37°C for 5min in presence of Alexa647-Dex (2mg/ml). The 
pulse was terminated by washing with chilled M1 on ice and surface C6-LacCer was back -
extracted by incubation of cells with 5% solution of defatted BSA in M1 at 4°C for 30min. 
Cells were subsequently fixed and imaged. In some experiments, cells were processed for 
immunostaining post-fixation. For HRP uptake, cells were plated in 92mm dishes, 
transfected with vector alone or ARF1 shRNA for 72h. Cells were pulsed with 1mg/ml 
HRP for 10min at 37ºC, then washed with chilled M1 and ascorbate buffer and 
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subsequently incubated with 5mg/ml BSA on ice. Cells were then scraped off the dish, 
counted and lysed using RIPA buffer (150mM NaCl, 50mM Tris-HCl, pH 7.5,
 
500?M 
EDTA, 100?M EGTA, 1.0% Triton X-100, and 1% sodium deoxycholate). Cell lysates 
from equal numbers of cells were used for total protein estimation and HRP activity. HRP 
activity was measured by monitoring the absorbance of reaction product, upon the 
incubating with equal amounts of H2O2/TMB solution, at 450nm on ELISA reader 
(BioRad). 
To quantify CFP-GPI exocytosis, cells were plated in HEPES-buffered HF-12, transfected 
with CFP-GPI DNA and post-transfection (10h), transferred to restrictive temperature of 
20°C. After 12h at 20°C, cells were incubated with 50μg/ml cycloheximide for an 
additional hour, followed with 1h at 37°C along with cycloheximide, with or without BFA, 
washed with pre-chilled M1, incubated with fluorescently labeled anti-GFP monoclonal 
antibody, and fixed prior to imaging.  
In the immunofluorescence assays, cells were fixed and permeabilized with 0.5% Tween20 
for 20min and then incubated with primary and fluorescently labeled secondary antibody 
where necessary. Under these conditions, minimal loss of fluid-phase endocytic tracers was 
detected. 
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